Comprehensive Metabolic Panel (CMP) Testing Industry Growth Expected to Reach $26.02 Billion by 2029 at a CAGR of 9.1% | Segmentation and Growth Opportunities
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Comprehensive Metabolic Panel (CMP) Testing Market Growth in 2025?
The market for comprehensive metabolic panel (CMP) testing has experienced significant growth in the past few years. The market size is projected to rise from $17.04 billion in 2024 to $18.39 billion in 2025, boasting a compound annual growth rate (CAGR) of 7.9%. The historical growth of this market can be credited to several factors such as an increase in chronic illnesses, the rising demand for comprehensive health evaluations, a healthcare focus on preventive care, growing prevalence of lifestyle-related conditions, and an approach to healthcare that prioritizes patients.
What Is the Forecast for the Comprehensive Metabolic Panel (CMP) Testing Market Size Through 2029?
Predictions for the comprehensive metabolic panel (CMP) testing market suggest a robust growth trajectory in the coming years, with an expected valuation of $26.02 billion in 2029, boasting a compound annual growth rate (CAGR) of 9.1%. The growth during the anticipated period can be attributed to factors such as the emergence of personalized medicine and precision healthcare, the inclusion of CMP testing in telehealth provisions, an increasing demand for comprehensive health examinations, a surge in wellness and preventive health measures, and evolving policies and regulations in the healthcare domain. Key trends that are expected to dominate the forecast period encompass continuous monitoring coupled with longitudinal tracking, reporting formats conducive to telemedicine, standardization of reference ranges, the incorporation of wearable health technology, and focus on patient education and involvement.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12362&type=smp
What are the Key Market Players in Comprehensive Metabolic Panel (CMP) Testing Market and How They’re Evolving?
Major companies operating in the comprehensive metabolic panel (CMP) testing market include Abbott Laboratories Inc., Siemens Healthineers AG, Mayo Clinic, Laboratory Corporation of America Holdings, Mercy, Mount Sinai Health System, Quest Diagnostics Incorporated, Sonic Healthcare Limited, Hologic Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Werfen SA, DiaSorin S.p.A., Randox Laboratories Ltd., ARUP Laboratories Inc., Invitae Corporation, Abaxis Inc., Metropolis Healthcare Limited, Clinical Reference Laboratory (CRL), Centogene AG, Spectra Laboratories, Unipath Systems Ltd., Scion Lab Services LLC, Weldon Biotech Pvt Ltd., Corona Pathology,Ulta Lab Tests LLC, Any Lab Test Now, Applied InGENuity Diagnostics LLC, Walk-In Lab LLC
What Are the Primary Growth Drivers in the Comprehensive Metabolic Panel (CMP) Testing Market?
The surge in cases of cardiovascular disorders and diabetes is anticipated to fuel the expansion of the comprehensive metabolic panel (CMP) testing market in the future. Cardiovascular conditions, which involve the heart or blood vessels, are often caused by atherosclerosis, a condition characterized by the accumulation of fatty deposits inside the arterial walls. High blood glucose levels are a strong indicator of diabetes. Comprehensive metabolic panel (CMP) blood tests are designed to monitor these glucose levels. Thus, as the number of diabetes and cardiovascular disorder cases rises, the need for efficient diagnosis methods like CMP blood testing will further boost the market’s growth. For example, statistics from the Australian Institute of Health and Welfare in December 2023 confirmed that there were 13,700 doctor-certified deaths due to CHD in 2020 which later rose to 14,100 in 2021 and 14,900 in 2022. Additionally, in June 2022, the International Diabetes Federation reported that the global incidence of diabetes had surged to 10.5%, with over half (44.7%) of the population still undiagnosed. Consequently, the escalating number of cardiovascular disorders and diabetes cases is propelling the expansion of the comprehensive metabolic panel (CMP) testing market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=12362&type=smp
What Are the Leading Segments in the Global Comprehensive Metabolic Panel (CMP) Testing Industry?
The comprehensive metabolic panel (CMP) testing market covered in this report is segmented –
1) By Disease: Kidney Disease, Liver Disease, Diabetes, Other Diseases
2) By Test Type: Proteins, Electrolytes, Kidney Tests, Liver Functional Tests, Glucose
3) By End User: Laboratories, Point Of Care (PoC)
Subsegments:
1) By Kidney Disease: Chronic Kidney Disease (CKD), Acute Kidney Injury (AKI), Glomerulonephritis
2) By Liver Disease: Hepatitis (Viral And Non-Viral), Cirrhosis, Fatty Liver Disease
3) By Diabetes: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes
4) By Other Diseases: Cardiovascular Diseases, Electrolyte Imbalances, Metabolic Disorders, Pancreatic Diseases
What Are the Key Market Trends in the Comprehensive Metabolic Panel (CMP) Testing Industry?
The rise in technological innovation is a significant developing trend in the comprehensive metabolic panel (CMP) testing market. Renowned firms in the CMP testing sector are embracing novel technological methods to maintain their market dominance. An example is HealthifyMe, a wellness and fitness services firm based in India, which unveiled its HealthifyPro, a flagship fitness program, in April 2022. The metabolic panel of the HealthifyPro plan is designed around a blood test that can evaluate over 80 distinct elements. The core constituents of HealthifyPro that helps to monitor the health of users includes a BIOS system, a smart weighing scale, health mentors, HealthifyMe’s AI-based assistant, and a metabolic panel. It synthesizes data on glucose variations, the users’ nutritional intake, and various physical activity routines to tailor a specific strategy for each user.
Access The Full Report Here:
What Is the Regional Outlook for the Comprehensive Metabolic Panel (CMP) Testing Market?
North America was the largest region in the comprehensive metabolic panel (CMP) testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the comprehensive metabolic panel (CMP) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12362
This Report Delivers Insight On:
1. How big is the comprehensive metabolic panel (cmp) testing market, and how is it changing globally?
2. Who are the major companies in the comprehensive metabolic panel (cmp) testing market, and how are they performing?
3. What are the key opportunities and risks in the comprehensive metabolic panel (cmp) testing market right now?
4. Which products or customer segments are growing the most in the comprehensive metabolic panel (cmp) testing market?
5. What factors are helping or slowing down the growth of the comprehensive metabolic panel (cmp) testing market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
